Identification of Null Allelic Variant of CYP2C8 In A Korean Population
NCT01872780
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
11
Enrollment
OTHER
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Rosiglitazone
GENETIC:
CYP2C8 genotype
Sponsor
Inje University